US Stock MarketDetailed Quotes

Bicycle Therapeutics (BCYC)

Watchlist
  • 4.090
  • -0.010-0.24%
Trading Jun 12 10:09 ET
285.53MMarket Cap-1.30P/E (TTM)

Bicycle Therapeutics (BCYC) Earnings Dates, Reports & Conference Call

BCYC 2026 Q1 Earnings Dates & Summary

Currency:USD--

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
7.50M
887.00K
-6.61M
Miss Est.
-24.84%
-91.11%
-88.17%
Net Income
-46.71M
-60.83M
-14.12M
Miss Est.
+23.12%
-0.12%
-30.23%
Buy

Jun 1, 2026

BCYC Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 4.658M--
--2026/Q2-- / 4.774M--
--2026/Q1887.000K / 7.499M--
--2025/Q447.955M / 7.076M--
--2025/Q311.734M / 8.250M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 4.658M--
--2026/Q2-- / 4.774M--
--2026/Q1887.000K / 7.499M--
--2025/Q447.955M / 7.076M--
--2025/Q311.734M / 8.250M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More